NextCure, Inc. (NXTC)
NASDAQ: NXTC · IEX Real-Time Price · USD
1.690
+0.010 (0.60%)
At close: Jul 19, 2024, 4:30 PM
1.790
+0.100 (5.92%)
Pre-market: Jul 20, 2024, 9:26 AM EDT
NextCure Market Cap
NextCure has a market cap or net worth of $47.27 million as of July 22, 2024. Its market cap has decreased by -5.07% in one year.
Market Cap
47.27M
Enterprise Value
-42.95M
1-Year Change
-5.07%
Ranking
Category
Stock Price
$1.69
Market Cap Chart
Since May 9, 2019, NextCure's market cap has decreased from $436.50M to $47.27M, a decrease of -89.17%. That is a compound annual growth rate of -34.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 47.30M | 48.74% |
| Dec 29, 2023 | 31.80M | -18.88% |
| Dec 30, 2022 | 39.20M | -76.36% |
| Dec 31, 2021 | 165.80M | -44.79% |
| Dec 31, 2020 | 300.30M | -76.57% |
| Dec 31, 2019 | 1.28B | 193.63% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DURECT | 49.35M |
| Modular Medical | 48.81M |
| Bionano Genomics | 48.13M |
| ARCA biopharma | 47.66M |
| Lantern Pharma | 47.45M |
| Vicarious Surgical | 46.79M |
| Apyx Medical | 46.77M |
| Elicio Therapeutics | 46.42M |